Parathyroid and calcium status in patients with thalassemia

被引：18

作者：

Goyal M. ^{[1
]}

Abrol P. ^{[1
]}

Lal H. ^{[2
,3
]}

机构：

[1] Department of Pediatrics, Post Graduate Institute of Medical Sciences, Pt. B.D. Sharma University of Health Sciences, Rohtak, Haryana

[2] Department of Biochemistry, Post Graduate Institute of Medical Sciences, Pt. B.D. Sharma University of Health Sciences, Rohtak, Haryana

[3] Department of Biochemistry, Maharaja Agrasen Medical College, Agroha (Hissar), Haryana

来源：

Indian Journal of Clinical Biochemistry | 2010年 / 25卷 / 4期

关键词：

Calcium; Parathyroid hormone; Thalassemia;

D O I：

10.1007/s12291-010-0071-5

中图分类号：

学科分类号：

摘要：

Thirty patients with thalassemia major receiving repeated blood transfusion were studied to see their serum parathyroid hormone (PTH) and calcium status. Serum PTH, serum and 24 h urinary calcium, and serum alkaline phosphatase, phosphorus, and albumin-corrected calcium levels were determined. Half of these patients, in addition to transfusion, were also supplemented with vitamin D (60,000 IU for 10d) and calcium (1500 mg/day for 3 months). Serum PTH, and serum and 24 h urinary calcium concentrations of the patients receiving transfusions were found to be significantly reduced while their serum alkaline phosphatase, phosphorus, and albumin-corrected calcium levels were not significantly altered when compared to the respective mean values for the control group. Vitamin D and calcium supplementation significantly increased their serum PTH and calcium levels. Supplementations also increased urinary excretion of calcium. The results thus suggest that patients with thalassemia have hypoparathyroidism and reduced serum calcium concentrations that in turn were improved with vitamin D and calcium supplementation. © Association of Clinical Biochemists of India 2010.

引用

页码：385 / 387

页数：2

共 15 条

[11]

Endres D.B., Villanueva R., Sharp Jr. C.F., Singer F.R., Measurement of parathyroid hormone, Endocrinology and Metabolism Clinics of North America, 18, 3, pp. 611-629, (1989)

[12]

Autio K.A., Mait J.E., Lesser M., Giardina P.J., Low bone mineral density in adolescents with β-thalassemia, J NY Acad Sci, 1054, (2005)

[13]

Aleem A., Al-Momen A.-K., Al-Harakati M.S., Hassan A., Al-Fawaz I., Hypocalcemia due to hypoparathyroidism in β-thalassemia major patients, Annals of Saudi Medicine, 20, 5-6, pp. 364-366, (2000)

[14]

Zamboni G., Marradi P., Tagliaro F., Parathyroid hormone, calcitonin and vitamin D metabolites in beta-thalassaemia major, European Journal of Pediatrics, 145, 1-2, pp. 133-136, (1986)

[15]

Napoli N., Carmina E., Bucchieri S., Sferrazza C., Rini G.B., Di F.G., Low serum levels of 25-hydroxy vitamin D in adults affected by thalassemia major or intermedia, Bone, 38, 6, pp. 888-892, (2006)

← 1 2 →